Survival Analysis Based on Clinicopathological Data from a Single Institution: Chemotherapy Intensity Would Be Enhanced in Patients with Positive Hormone Receptors and Positive HER2 in China Who Cannot Afford the Target Therapy

Table 4

Cox proportional hazards model of biological factors/treatment factors.

Parameters	Death		Tumor progression
	Sig.	EXP(𝐵)	Sig.	EXP(𝐵)
Biological factors
Age	0.024	1.089	0.034	1.076
Family history	0.924	1.054	0.850	0.905
Menopause	0.045	5.275	0.047	4.453
Histological grade	0.767	0.875	0.407	1.437
Tumor diameter	0.104	1.295	0.052	1.348
Lymph node metastasis	0.005	10.063	0.006	6.973
Cancer thrombosis	0.519	0.668	0.395	0.617
ER	0.488	0.637	0.606	0.735
PR	0.960	1.030	0.874	1.091
HER2	0.012	4.318	0.009	3.882
Ki67	0.979	0.987	0.635	1.255
P53	0.399	1.629	0.280	1.752
Treatment factors
Operation	0.338	0.366	0.236	0.291
Chemotherapy	0.048	1.633	0.042	1.596
Radiotherapy	0.144	2.195	0.231	1.800
Endocrine therapy	0.452	0.748	0.226	0.645